Estonia to introduce the future vision of personalized medicine at Cannes Lions Health
Ain Aaviksoo, Deputy Secretary General for E-services and Innovation at the Ministry of Social Affairs, has been confirmed as a presenter at the Cannes Lions Health conference, to be held on 18 and 19 June. Aaviksoo will speak to an audience of international experts about the personalized health system supported with digital solutions.
“In the light of continuous development of technology, personalized medicine is a tangible future where the health and gene information of a person allows the provision of patient-friendly health services both for prevention and, if necessary, for treatment,” says Aaviksoo. “The health care of the future will be preventive, personalized and patient inclusive.”
According to Aaviksoo, Estonia’s advantage is its technological capability to test new solutions in a secure way. “With X-road we already have an infrastructure that allows secure sharing and using of data stored about people in various sources, including the data in the gene bank. Moreover, people are very ready to enjoy novel and convenient services by combining available data. When we bring all these different conditions together, it is possible to create solutions that help people maintain their health, monitor and prevent problems,” says Aaviksoo.
Ain Aaviksoo will present a vision about a fully personalized health system supported by digital solutions at the Cannes Lions Health Conference. Part of the presentation will be a demonstration of DNA-testing, instructed by the Communication Manager of the Estonian Genome Center, Ms Annely Allik.
In Estonia, the national programme for developing personalized medicine and its application in health care in Estonia for 2016–2020 is being prepared with a view to developing personalized medicine.
More news on the same subject
In 2018 more than 100 000 new participants have joined the genome project. The state will allocate another 2.3 million euros for 2019 to enable at least 50 000 more people to join the Estonian Biobank. In the next phase of the project during the years 2019-2022 the plan is to integrate genetic data as a part of the everyday medical practice, to give people feedback about their personal genetic risks.
From today, January 21, it will be possible to buy prescription medicines from Estonian pharmacies with a digital prescription issued in Finland. Estonians will have the opportunity to buy prescription drugs outside Estonia by the end of 2019. Estonia and Finland will become the first two countries in Europe to exchange digital prescription data.